Form 8-K - Current report:
SEC Accession No. 0001193125-25-235081
Filing Date
2025-10-09
Accepted
2025-10-09 07:02:24
Documents
11
Period of Report
2025-10-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20251009.htm   iXBRL 8-K 51346
2 EX-99.1 neog-ex99_1.htm EX-99.1 517440
  Complete submission text file 0001193125-25-235081.txt   707686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20251009.xsd EX-101.SCH 30832
14 EXTRACTED XBRL INSTANCE DOCUMENT neog-20251009_htm.xml XML 4728
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 251383598
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)